Sub-Q Bionics Closes $1.5M Pre-Seed Round to Advance Next-Generation Solution for Lymphedema Care
STILLWATER, Minn. & TEL AVIV, Israel, March 31, 2026–(BUSINESS WIRE)–Sub-Q Bionics, a medical device company developing next-generation solutions
Sub-Q Bionics Announces Licensing Agreement to Advance Lymphedema Care
STILLWATER, Minn. & TEL AVIV, Israel–(BUSINESS WIRE)–Sub‑Q Bionics, a medical device company developing an innovative implantable
The 13th UK National Lymphoedema Conference
This conference brings clinical and medtech professionals together to discuss clinical standards of care and advancements in technology for managing lymphedema.
MedTech World Middle East
Following our successful conference in Malta in November, the SubQ team will now attend the Dubai conference as well.
Medtech MVP
Medtech MVP, june 16-17, 2025: SubQ Bionics had the opportunity to pitch in front of investor’s at the Medtech MVP Pitch Contest 2025, which is part of the Medtech MVP Conference.
mHealth in Japan
mHealth Tokyo, June 23-27, 2025: CEO Jordan Pollack networked with other Medtech entrepreneurs at the Tokyo Femtech event, organized by mHealth Israel